TY - JOUR
T1 - Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group
AU - Sardanelli, Francesco
AU - Boetes, Carla
AU - Borisch, Bettina
AU - Decker, Thomas
AU - Federico, Massimo
AU - Gilbert, Fiona J.
AU - Helbich, Thomas
AU - Heywang-Köbrunner, Sylvia H.
AU - Kaiser, Werner A.
AU - Kerin, Michael J.
AU - Mansel, Robert E.
AU - Marotti, Lorenza
AU - Martincich, Laura
AU - Mauriac, Louis
AU - Meijers-Heijboer, Hanne
AU - Orecchia, Roberto
AU - Panizza, Pietro
AU - Ponti, Antonio
AU - Purushotham, Arnie D.
AU - Regitnig, Peter
AU - del Turco, Marco Rosselli
AU - Thibault, Fabienne
AU - Wilson, Robin
AU - Heywang-Kobrunner, S.H.
AU - Mansel, RE
PY - 2010
Y1 - 2010
N2 - The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point
AB - The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point
U2 - https://doi.org/10.1016/j.ejca.2010.02.015
DO - https://doi.org/10.1016/j.ejca.2010.02.015
M3 - Article
C2 - 20304629
SN - 0959-8049
VL - 46
SP - 1296
EP - 1316
JO - European journal of cancer (Oxford, England
JF - European journal of cancer (Oxford, England
IS - 8
ER -